II
RETA

Ibex Investors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Ibex Investors’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,239
Closed -$238K – 141
2018
Q4 		$238K Buy
+4,239
New +$238K 0.04% 57